Sign Up to like & get
recommendations!
0
Published in 2018 at "Analytical chemistry"
DOI: 10.1021/acs.analchem.8b01776
Abstract: A T790M secondary mutation in epidermal-growth-factor receptor (EGFR) is the most well-established EGFR-tyrosine-kinase-inhibitor (TKI) resistance marker in non-small-cell lung cancer (NSCLC). The current methods to rapidly and accurately detect T790M in clinical practice are not…
read more here.
Keywords:
tumor;
lab ddpcr;
dna;
t790m ... See more keywords